AviadoBio Presents New Preclinical Data Validating the vMiX™ Platform for AVB-406 in Alzheimer’s Disease and for AVB-SNCA in Parkinson’s Disease at ESGCT 2026 Business Wire Single intravenous dose of AVB-406 maintained MAPT mRNA knockdown and reduced total tau protein by 84% at six months with no adverse clinical signs First preclinical data for AVB-SNCA show up to 80% SNCA knockdown in human neurons, supporting development as a one-time therapy for synucleinopathies
LegitScript Report Reveals Contrasting EU and UK Product Safety Risks Ahead of Holiday Shopping Season Business Wire As regulatory scrutiny and consumer safety stakes rise, year-to-date findings highlight regional enforcement differences and shared warning signs for platforms, sellers, and consumers
Aera Technology Unveils Six Agentic Innovations to Power the Decision-Centric Enterprise Business Wire New capabilities make decision intelligence faster to build, govern, and scale — turning business challenges into automated action and measurable outcomes
Meta Cell Technology Brings Together International Medical Educators for First MCT Academy – Train the Trainers October 26, 2026 Physicians and scientific experts from MCT’s international network met in Crete for advanced medical education, scientific exchange and the formal recognition of MCT Trainers.
Five years of U.S. real-world evidence reinforce the durable effectiveness and long-term persistence of ViiV Healthcare’s Cabenuva October 21, 2026 77% of participants remained in care and on long-acting HIV treatment, Cabenuva, with a median treatment duration of 18 months Among individuals switching to Cabenuva, 94% had a last viral load <50 copies/mL and 81% maintained continuous viral suppression with only 1% experiencing confirmed virologic failure Study demonstrated real-world impact across a diverse study population, with Black (43%) and Hispanic/Latine (32%) adults representing three-quarters of participants; overall, participants included individuals aged 50+ (23%) and those with BMI≥30 kg/m2 (30%)
LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November October 21, 2026 LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that members of the Company’s Executive Leadership Team will provide general business updates during fireside chats at the four following November healthcare conferences: UBS Global Healthcare Conference on Mon., Nov. 9, from 11-11:35 a.m. EST in Palm Beach, Fla. 8th Annual Wolfe Research Healthcare [...]
Bear Robotics Launches KINO-2 Through Engineering Collaboration with NVIDIA October 21, 2026 Bear combines expertise in robotics hardware and software with operational experience across 5,000+ customer sites to bring emerging NVIDIA Physical AI technologies into production.
Sapia.ai Offers Rejected Candidates an AI Career Coach, Launching Love-jection at UNLEASH Paris October 21, 2026 Unsuccessful applicants can get free guidance on their strengths and the roles that suit them
Sihoo to Showcase Next-Generation Ergonomic Office Experience at ORGATEC 2026 October 20, 2026 With ORGATEC 2026 approaching, ergonomic seating specialist Sihoo will present its next-generation workplace solutions at Hall 8.1, Booths A-060 & B-061. In line with the exhibition theme, “From rooms to relationships: designing spaces in an ever-changing world,” Sihoo will demonstrate how adaptive ergonomic design supports changing postures and evolving needs in modern workplaces. This press [...]
STARTEEPO Sends Letter to Xerox Board in Advance of Third-Quarter Earnings October 19, 2026 Company’s Third Largest Shareholder Expects Update on Increased Transparency, Strategic Review of Xerox Financial Services Business Unit, and Continued Deleveraging STARTEEPO Chairman František Bostl to Address Xerox Investment at Skytop Conference in London